TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 173 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $871,570 | +4150233.3% | 97,491 | +9749000.0% | 0.00% | – |
Q4 2022 | $21 | -99.9% | 1 | -99.9% | 0.00% | – |
Q3 2022 | $30,000 | +50.0% | 1,199 | +53.7% | 0.00% | – |
Q2 2022 | $20,000 | -99.1% | 780 | -99.1% | 0.00% | -100.0% |
Q1 2022 | $2,241,000 | +41.2% | 86,934 | +70.1% | 0.01% | +66.7% |
Q4 2021 | $1,587,000 | +1988.2% | 51,112 | +1527.3% | 0.00% | – |
Q3 2021 | $76,000 | -92.2% | 3,141 | -95.3% | 0.00% | -100.0% |
Q2 2021 | $969,000 | -87.7% | 66,398 | -78.9% | 0.00% | -86.7% |
Q1 2021 | $7,861,000 | +8.7% | 314,817 | +18.7% | 0.02% | 0.0% |
Q4 2020 | $7,229,000 | – | 265,234 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
CM Management, LLC | 60,000 | $875,000 | 0.63% |
Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |